Aggregate Analysis of Monoclonal Antibodies using bioZen SEC-3 Column

Abstract:

Monoclonal antibody (mAb) aggregates have significant implications in safety, immunogenicity, and efficacy for therapeutic drug development. Size exclusion chromatography (SEC) is one of the laboratory methods used to determine the extent of aggregation of a protein. This method demonstrates the separation of three mAbs trastuzumab, infliximab, and cetuximab with the use of the bioZen SEC-3 column.

Document Type:

Technical Notes

Industries:

Pharmaceutical/Biopharmaceutical Life Science

Techniques:

HPLC / UHPLC

Brands:

bioZen

PDF Link:

Click here